ASEP Medical Holdings Inc stock analysis
Want to see TSE:ASEP full AI Analyst Report?
ASEP Medical Holdings Inc (ASEP) Stock Price & Analysis
ASEP Stock Chart & Stats
- Day’s Range
- CAD 0.10 - CAD 0.10
- 52-Week Range
- CAD 0.06 - CAD 0.50
- Previous Close
- CAD 0.10
- Volume
- N/A
- Average Volume (3M)
- 5,863
- Market Cap
- CAD 1.59M
- Enterprise Value
- CAD 3.93M
- Total Cash (Recent Filing)
- CAD 76.32K
- Total Debt (Recent Filing)
- CAD 177.50K
- Price to Earnings (P/E)
- ―
- Beta
- -0.78
- Next Earnings
- Dec 01, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage
Very low leverage limits balance-sheet pressure while the company funds development in an early-stage biotech setting. Modest debt reduces interest and refinancing exposure, preserves financing flexibility, and gives management more room to pursue scientific and commercial milestones.
Improving Free Cash Flow
The improvement in free cash flow suggests some progress in cost control or cash-flow timing, even though the company still burns cash. If sustained, better cash discipline could extend financial runway and reduce the pace at which external funding is required.
Narrower Operating Losses
A reduction in operating losses indicates that the underlying cost structure may be moving in a better direction. Continued improvement could support eventual operating leverage as diagnostic or therapeutic programs mature, although profitability has not yet been achieved.
Bears Say
Persistent Cash Burn
Ongoing negative operating and free cash flow means the business is not currently funding itself through operations. Persistent burn can shorten financial runway, increase reliance on financing, and constrain the company’s ability to advance programs without additional capital.
Severe Unprofitability
The extremely negative margin profile shows that current revenue is far from covering the cost base. Negative gross profit and substantial losses weaken earnings quality, limit internally funded investment, and make a durable commercial model dependent on significant improvement in scale or economics.
Declining Equity Base
Declining equity alongside deeply negative returns indicates that capital is being consumed without producing adequate shareholder returns. This weakens financial resilience over time and may increase the need for future capital support as the company develops its programs.
ASEP Medical Holdings Inc News
Asep Medical Restructures Stakes in ABT and Sepset While Preserving Economic Upside
The latest announcement is out from ASEP Medical Holdings Inc ( ($TSE:ASEP) ). Asep Medical Holdings Inc., a biotechnology-focused investment issuer based in Victoria, BC, concentrates on diagnostic and therapeutic
Asep Medical Adds Industry Veteran O’Shaughnessy to Board to Drive Sepsis and Anti-Biofilm Strategy
ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has issued an announcement. Asep Medical Holdings Inc., a Canadian biotech R&D firm with patented diagnostic and therapeutic technologies and subsidiaries in sepsis
Asep Medical Names Dr. Richard Heinzl Interim CEO Amid Push to Advance Diagnostic Technologies
ASEP Medical Holdings Inc ( ($TSE:ASEP) ) just unveiled an update. Asep Medical Holdings Inc. has appointed board member Dr. Richard Heinzl as interim chief executive officer and chairman, replacing
ASEP FAQ
What was ASEP Medical Holdings Inc’s price range in the past 12 months?
What is ASEP Medical Holdings Inc’s market cap?
When is ASEP Medical Holdings Inc’s upcoming earnings report date?
How were ASEP Medical Holdings Inc’s earnings last quarter?
Is ASEP Medical Holdings Inc overvalued?
Does ASEP Medical Holdings Inc pay dividends?
What is ASEP Medical Holdings Inc’s EPS estimate?
How many shares outstanding does ASEP Medical Holdings Inc have?
What happened to ASEP Medical Holdings Inc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ASEP Medical Holdings Inc?
What is the TipRanks Smart Score and how is it calculated?
Company Description
ASEP Medical Holdings Inc
Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard Heinzl
- Employees
- 6
- Website
- asepmedical.com
- Address
- 4400 Chatterton Way, Victoria, BC, V8X 5J3, CA
ASEP Medical Holdings Inc (ASEP) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 15 |
| Technical Analysis | 3 | 2 | 4 |
| Moving Averages | 1 | 0 | 11 |









